HIV prevalence and risk behaviours among injecting drug users in six indonesian cities implications for future HIV prevention programs

Morineau, Guy; Bollen, Liesbeth J. M.; Syafitri, Rizky Ika; Nurjannah, Nurjannah; Mustikawati, Dyah Erti; Magnani, Robert J.

doi:10.1186/1477-7517-9-37

Cited by 30 publications

(24 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In many parts of the world where IDU has been a major driver of the HIV epidemic, sexual transmission of HIV from PWID to their sexual partners has increased (5, 11, 32). IDU-concentrated epidemics are likely to have initiated heterosexually transmitted epidemics in Argentina, Brazil, China, Indonesia, the Netherlands, and Ukraine (5).…”

Section: Drug-using Populations and The Hiv Epidemicmentioning

confidence: 99%

Drug use as a driver of HIV risks

El‐Bassel

Shaw

Dasgupta

et al. 2014

Current Opinion in HIV and AIDS

View full text Add to dashboard Cite

Purpose of Review We reviewed papers published in 2012–2013 that focused on re-emerging and emerging injection and non-injection drug use trends driving HIV risk behaviors and transmission in some parts of the world. Recent Findings While HIV incidence has declined in many countries, HIV epidemics remain at troubling levels among key drug using populations including females who inject drugs (FWID), FWID who trade sex, sex partners of people who inject drugs (SP-PWID), young PWID, and people who use non-injection drugs in a number of low- and middle- income countries such as in Central Asia, Eastern Europe, Southeast Asia, and parts of Africa. Summary HIV epidemics occur within contexts of global economic and political forces, including poverty, human rights violations, discrimination, drug policies, trafficking, and other multi-level risk environments. Trends of injection and non-injection drug use and risk environments driving HIV epidemics in Central Asia, Eastern Europe, Southeast Asia, and parts of Africa call for political will to improve HIV and substance use service delivery, access to combination HIV prevention, and harm reduction programs.

show abstract

Section: Drug-using Populations and The Hiv Epidemicmentioning

confidence: 99%

Drug use as a driver of HIV risks

El‐Bassel

Shaw

Dasgupta

et al. 2014

Current Opinion in HIV and AIDS

View full text Add to dashboard Cite

show abstract

“…Opioid dependence, HIV and HCV are volatile, intertwined epidemics that impact tens of millions of people globally [1–6]. Efforts are underway throughout the world to increase access to and retention on treatment for opioid dependence with methadone or buprenorphine.…”

Section: Expert Commentarymentioning

confidence: 99%

“…Opioid dependence, particularly the injection of heroin, and infections with HIV and hepatitis C (HCV) are explosive, intertwined epidemics that adversely impact tens of millions of people globally [1–6]. Approximately 5% of the global population, or 230 million people have used drugs[7].…”

Section: Introductionmentioning

confidence: 99%

A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice

Bruce

Moody

Altice

et al. 2013

Expert Review of Clinical Pharmacology

View full text Add to dashboard Cite

Global access to opioid agonist therapy and HIV/HCV treatment is expanding but when used concurrently, problematic pharmacokinetic and pharmacodynamic interactions may occur. Review of articles from 1966 into 2012 in Medline using the following keywords: HIV, AIDS, HIV therapy, HCV, HCV therapy, antiretroviral therapy, HAART, drug interactions, methadone, and buprenorphine. Additionally, abstracts from national and international meetings and a review of conference proceedings were conducted; selected reports were reviewed as well. The metabolism of both opioid and antiretroviral therapies, description of their known interactions, and clinical implications and management of these interactions are reviewed. Important pharmacokinetic and pharmacodynamic drug interactions affecting either methadone or HIV medications have been demonstrated within each class of antiretroviral agents. Drug interactions between methadone, buprenorphine and HIV medications are known and may have important clinical consequences. Clinicians must be alert to these interactions and have a basic knowledge regarding their management.

show abstract

“…HIV prevalence among Indonesian injectors was estimated to range from 42.8 to 56 per cent (Morineau et al, 2012).…”

Section: Epidemiology Of Idu and Hivmentioning

confidence: 99%

Compulsory treatment of drug users in Asia: designed to torture?

Dolan

Worth

Wilson

2015

International Journal of Prisoner Health

View full text Add to dashboard Cite

Purpose – Injecting drug use is a global concern, with an estimated 16 million people who inject drugs (PWIDs) in over 148 countries. A number of Asian countries detain PWIDs for compulsory treatment. The paper aims to discuss this issue. Design/methodology/approach – The authors reviewed the literature on compulsory drug treatment in seven Asian countries. Findings – The authors identified 1,269 closed settings which held over 600,000 drug users in eight countries. The average detainee was aged from 20 to 30 years and was predominantly male. HIV risk behaviour continued in detention in some countries. In most countries treatment comprised physical labour, military drills. Methadone maintenance treatment and antiretroviral therapy were rarely available. No data were located to show detention in a closed setting treated drug dependency. Issues of concern were; no due legal process for the detention of drug users, lack of evidence-based drug treatment, lack of HIV prevention and treatment, abusive conditions, forced labour and exercise, arbitrary exit procedures and very high relapse rates. Research limitations/implications – The review of compulsory treatment of drug users failed to find any evaluation of effective drug treatment for detainees. Instead serious breaches in human rights conditions were evident. Prominent international organisations have called for the compulsory treatment of drug users to cease. Practical implications – Many countries are spending vast amounts of funding on ineffective treatments for drug users. Social implications – Funding should be directed to community-based drug treatments that have been shown to work. Originality/value – This is the largest review of compulsory treatment of drug users to date.

show abstract

HIV prevalence and risk behaviours among injecting drug users in six indonesian cities implications for future HIV prevention programs

Cited by 30 publications

References 11 publications

Drug use as a driver of HIV risks

Drug use as a driver of HIV risks

A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice

Compulsory treatment of drug users in Asia: designed to torture?

Contact Info

Product

Resources

About